These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2043529)

  • 1. Experimental treatment of bupivacaine cardiotoxicity: what is the best choice?
    de La Coussaye JE; Bassoul BP; Gagnol JP; Sassine A; Eledjam JJ
    Reg Anesth; 1991; 16(2):120-2. PubMed ID: 2043529
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of bupivacaine-induced cardiac arrhythmias in hypoxic and hypercarbic pigs with amiodarone or bretylium.
    Haasio J; Pitkänen MT; Kyttä J; Rosenberg PH
    Reg Anesth; 1990; 15(4):174-9. PubMed ID: 2073482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupivacaine cardiovascular toxicity: comparison of treatment with bretylium and lidocaine.
    Kasten GW; Martin ST
    Anesth Analg; 1985 Sep; 64(9):911-6. PubMed ID: 4025854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications and surveillance of amiodarone and bretylium treatments].
    Trigano JA; Torresani J
    Rev Prat; 1975 Oct; 25(45):3529-32, 3537-8, 3541-4. PubMed ID: 1209119
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drugs for treatment of ventricular arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of bretylium, lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1969 Oct; 37(2):526P-527P. PubMed ID: 5348446
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council.
    von Planta M; Chamberlain D
    Resuscitation; 1992 Dec; 24(3):227-32. PubMed ID: 1336883
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug interactions in bupivacaine-induced cardiotoxicity.
    Wulf H
    Reg Anesth; 1991; 16(3):187-8. PubMed ID: 1883779
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug interactions in bupivacaine-induced cardiotoxicity.
    Wulf H
    Reg Anesth; 1991; 16(2):116-7. PubMed ID: 2043526
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiazide-induced hypokalemia with associated major ventricular arrhythmias. Report of a case and comment on therapeutic use of bretylium.
    Redleaf PD; Lerner IJ
    JAMA; 1968 Nov; 206(6):1302-4. PubMed ID: 5695800
    [No Abstract]   [Full Text] [Related]  

  • 12. [New drug in the treatment of arrhythmia: bretylium toxilate].
    Jacovella G
    Clin Ter; 1970 Jul; 54(1):85-9. PubMed ID: 5481242
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug corner: bretylium tosylate (Bretylol).
    Crit Care Nurse; 1980; 1(1):68-9. PubMed ID: 6914232
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bretylium tosylate as an antiarrhythmic agent].
    Borkowski PJ
    Kardiol Pol; 1970; 13(2):195-8. PubMed ID: 5433233
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bretylium tosylate, a new original anti-arrhythmic agent].
    Warembourg H; Vermeersch M; Pauchant M; Ducloux G; Delebecque H
    Lille Med; 1972 Feb; 17(2):201-4. PubMed ID: 5038050
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bretylium tosilate in cardiac arrhythmia therapy].
    Maranhão MF; Germiniani H; Rojas RR; Lacerda FS; Cunha GP
    Arq Bras Cardiol; 1971 Feb; 24(1):17-23. PubMed ID: 5123190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with the anti-arrhythmic activity of bretylium tosylate].
    Calabrese P; Rizzon P
    Boll Soc Ital Cardiol; 1972; 17(7):407-12. PubMed ID: 4650835
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bretylium Tosylate in the therapy of malignant arrhythmia. First results].
    Heinrich KW; Effert S
    Med Welt; 1973 Jun; 24(24):1000-2. PubMed ID: 4751417
    [No Abstract]   [Full Text] [Related]  

  • 20. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.